Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury

Heart

Volumn 103, Issue 8, 2017, Pages 616-622

  Cediel, German ^a,b   Gonzalez Del Hoyo, Maribel ^a,b   Carrasquer, Anna ^a,b   Sanchez, Rafael ^a   Boqué, Carme ^a,b   Bardají, Alfredo ^a,b  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIAC TROPONIN 1 CLIA; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; GROUPS BY AGE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE OXYGEN CONSUMPTION; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; NON ISCHEMIC MYOCARDIAL INJURY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; TYPE 1 MYOCARDIAL INFARCTION; TYPE 2 MYOCARDIAL INFARCTION; BLOOD; DISEASE COURSE; EPIDEMIOLOGY; HOSPITAL EMERGENCY SERVICE; INCIDENCE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SPAIN; TIME FACTOR; UNIVERSITY HOSPITAL; UPREGULATION; VERY ELDERLY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BIOMARKERS; DISEASE PROGRESSION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT READMISSION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TIME FACTORS; TROPONIN I; UP-REGULATION;

EID: 84992154307     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2016-310243     Document Type: Article

References (30)

1. Thygesen K, Alpert JS, White HD, et al. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
2. Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010;31:2197-204.
3. Wong P, Ramsewak A, Murray S, et al. Effects of comorbidity and hospital care on 6-month mortality in patients with elevated cardiac troponin T. Postgrad Med J 2007;83:332-7.
4. Saaby L, Poulsen TS, Hosbond S, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med 2013;126:789-97.
5. Sarkisian L, Saaby L, Poulsen TS, et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury and non-elevated troponins. Am J Med 2016;129:446.e5-21.
6. Sanchis J, Bardají A, Bosch X, et al. Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage. Am Heart J 2012;164:194-200.e1.
7. Pavasini R, d'Ascenzo F, Campo G, et al. Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Cardiol 2015;191:187-93.
8. Ammann P, Fehr T, Minder EI, et al. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001;27:965-9.
9. McFalls E, Larsen G, Johnson G, et al. Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level. Am J Med 2011;124:630-5.
10. Smith SC, Ladenson JH, Mason JW, et al. Elevations of cardiac troponin I associated with myocarditis: experimental and clinical correlates. Circulation 1997;95:163-8.
11. Meyer T, Binder L, Hruska N, et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000;36:1632-6.
12. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-67.
13. Bardají A, Cediel G, Carrasquer A, et al. Troponin elevation in patients without acute coronary syndrome. Rev Esp Cardiol 2015;68:469-76.
14. Sandoval Y, Thordsen SE, Smith SW, et al. Cardiac troponin changes to distinguish type 1 and type 2 myocardial infarction and 180-day mortality risk. Eur Heart J Acute Cardiovasc Care 2014;3:317-25.
15. Baron T, Hambraeus K, Sundström J, et al. Type 2 myocardial infarction in clinical practice. Heart 2015;101:101-6.
16. Stein GY, Herscovici G, Korenfeld R, et al. Type-II Myocardial Infarction - patient characteristics, management and outcomes. PLoS ONE 2014;9:e84285.
17. El-Haddad H, Robinson E, Sweet K, et al. Prognostic implications of type 2 myocardial infarctions. World J Cardiovasc Dis 2012;2:237-41.
18. Jensen JK, Atar D, Mickley H. Mechanism of troponin elevations in patients with acute ischemic stroke. Am J Cardiol 2007;99:867-70.
19. Voss EM, Sharkey SW, Gernert AE, et al. Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium. Infarct sizing using serum profiles. Arch Pathol Lab Med 1995;119:799-806.
20. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol 2011;57:2406-8.
21. Korff S, Katus HA, Giannitsis E. Differential diagnosis of Elevated troponins. Heart 2006;92:987-93.
22. Melberg T, Burman R, Dickstein K. The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol 2010;139:228-33.
23. Javed U, Aftab W, Ambrose JA, et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. Am J Cardiol 2009;104:9-13.
24. Brunner NW, Scheuermeyer FX, Grafstein E, et al. Outcomes of non-acute coronary syndrome patients discharged from the emergency department with troponin positivity. CJEM 2014;16:41-52.
25. Fundarò C, Guzzetti S. Prognostic value of stable troponin T elevation in patients discharged from emergency department. J Cardiovasc Med 2010;11:276-80.
26. Saaby L, Poulsen TS, Diederichsen AC, et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med 2014;127:295-302.
27. Baron T, Hambraeus K, Sundström J, et al. Impact on long-term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction. Am J Med 2016;129:398-406.
28. Mochmann HC, Scheitz JF, Petzold GC, et al. Coronary Angiographic findings in acute ischemic stroke patients with elevated cardiac troponin: the troponin elevation in acute ischemic stroke (TRELAS) study. Circulation 2016;133:1264-71.
29. Collinson P, Lindahl B. Type 2 myocardial infarction: the chimaera of cardiology? Heart 2015;101:1697-703.
30. Spatz ES, Curry LA, Masoudi FA, et al. The variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) classification system: a taxonomy for young women with acute myocardial infarction. Circulation 2015;132:1710-18.